Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticlePsoriatic Arthritis

Current Smoking Is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis

Dilek Solmaz, Umut Kalyoncu, Ilaria Tinazzi, Sibel Bakirci, Ozun Bayindir, Atalay Dogru, Ediz Dalkilic, Gezmis Kimyon, Cem Ozisler, Gozde Yildirim Cetin, Levent Kilic, Ahmet Omma, Meryem Can, Sema Yilmaz, Abdulsamet Erden and Sibel Zehra Aydin
The Journal of Rheumatology September 2020, 47 (9) 1354-1358; DOI: https://doi.org/10.3899/jrheum.190722
Dilek Solmaz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dilek Solmaz
Umut Kalyoncu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Umut Kalyoncu
Ilaria Tinazzi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sibel Bakirci
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sibel Bakirci
Ozun Bayindir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ozun Bayindir
Atalay Dogru
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Atalay Dogru
Ediz Dalkilic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ediz Dalkilic
Gezmis Kimyon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gezmis Kimyon
Cem Ozisler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cem Ozisler
Gozde Yildirim Cetin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gozde Yildirim Cetin
Levent Kilic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ahmet Omma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ahmet Omma
Meryem Can
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meryem Can
Sema Yilmaz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sema Yilmaz
Abdulsamet Erden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abdulsamet Erden
Sibel Zehra Aydin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sibel Zehra Aydin
  • For correspondence: saydin@toh.ca
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective. The effect of smoking in psoriatic arthritis (PsA) is under debate. Our aim was to test whether smoking is increased in axial PsA (axPsA).

Methods. Included in the analysis were 1535 patients from PsArt-ID (PsA-International Database). The effect of smoking on axPsA (compared to other PsA phenotypes) and radiographic sacroiliitis were investigated.

Results. Current smoking was more common in axPsA (28.6% vs 18.9%, p < 0.001). It also was found as an independent predictor of axPsA (OR 1.4) and radiographic sacroiliitis (OR 6.6).

Conclusion. Current smoking is significantly associated with both axPsA and radiographic sacroiliitis in patients with PsA.

Key Indexing Terms:
  • AXIAL PSORIATIC ARTHRITIS
  • SMOKING
  • SACROILIITIS

Psoriatic arthritis (PsA) is a heterogeneous disease, with diverse disease manifestations1. Several genetic and environmental factors have been implicated as the mechanism underlying PsA, one of the latter being smoking. Although smoking has long been recognized as a risk factor in multiple immune-mediated diseases, there is inconsistent data in the literature regarding its role in PsA. Studies on the general population had demonstrated that smoking increases the risk of PsA2,3. However, looking at the risk of developing PsA in patients with psoriasis, 2 studies had shown that smoking does not have any effects on the risk of PsA, whereas 2 others demonstrated a decreased risk3,4,5,6.

Smoking has been recognized as a prognostic marker in axial spondyloarthritis (axSpA) including ankylosing spondylitis (AS), with poorer outcomes, more severe disease, and radiographic damage7,8. A population-based study demonstrated that incident AS was associated with current smoking, but not with former smoking8. To date, there is no information on the effect of smoking as a risk factor for axial PsA (axPsA).

We hypothesize that smoking is increased in axPsA, similar to AS. Therefore, in this study we aimed to (1) understand the frequency of smoking in axPsA in comparison to non-axPsA, and (2) investigate risk factors of axPsA, with a focus on smoking.

MATERIALS AND METHODS

Patient selection and data collection

The Psoriatic Arthritis-International Database (PsArt-ID) is a prospective, multicenter registry in PsA that was initially developed in Turkey in 2014, with participation from Canada since 2015 and Italy since 20189. Ethics approval was obtained from the local ethics committees [Hacettepe University Ethics Board, Ankara (GO 14/578); Ottawa Health Science Network Research Ethics Board, Ottawa (20160436-01H); Sacro Cuore-Don Calabria Hospital, Italy (F8MRG)] and all patients gave informed consent prior to data collection. Patients were consecutively placed in the registry with the aim of investigating real-life data using a Web-based system (www.trials-network.org), and the details of the registry have been previously published9. In addition, smoking status was categorized as never, current smoker, or ex-smoker at enrollment, with duration and intensity to calculate smoking packs-year. AxPsA definition was clinicians’ decision of axPsA, based on inflammatory back pain according to the physician and the clinician’s final judgment, but not mandating any imaging. However, whenever possible, radiographs of the sacroiliac joints (SIJ) were read and scored centrally by an experienced rheumatologist (SZA) blinded to the clinical data, and further analyses were made based on the imaging findings. Those readings were done according to the definitions used in the modified New York (mNY) classification criteria10 and radiographic sacroiliitis defined as ≥ grade II both sides or ≥ grade III unilaterally.

Statistical analysis

Two group comparisons were made by Fisher’s exact, chi-square, Student t, or Mann-Whitney U tests, as appropriate. ANOVA or Kruskall-Wallis test was used in multiple groups’ comparisons, with Bonferroni correction. Risk factors for axial disease based on the literature and clinically relevant factors were carried to multivariable analysis; they included age, sex, body mass index (BMI), disease duration, disease subtypes, disease activity scores, function, and C-reactive protein. They were tested in univariable analyses and factors with a significance level of p < 0.05. An intraobserver agreement analysis was done on 28 SIJ radiographs by reading the same images 3 months apart, which revealed good intraobserver agreement (κ = 0.79)11. SPSS software (version 22.0, IBM Corp.) was used to conduct all statistical analyses.

RESULTS

Baseline characteristics

For this study, 1535 patients who had smoking data were included. Among these patients, 562 (36.6%) were male and the mean age was 46.9 (13.4) years. For smoking, 334 patients (21.8%) were current smokers, 324 (21.1%) had quit smoking, and 877 (57.1%) had never smoked (Table 1, and Supplementary Table 1, available from the authors on request).

View this table:
  • View inline
  • View popup
Table 1.

Demographic features of axial psoriatic arthritis (axPsA) and non-axial PsA (non-axPsA).

The effect of smoking on disease outcomes

Current and ex-smokers were more frequently males (Supplementary Table 2, available from the authors on request). Ever-smoking was also more frequent in axPsA (48.2% vs 40.6%, p = 0.006). Current smokers were significantly younger than ex-smokers and non-smokers, and also had had more frequent nail disease. BMI was slightly lower in current smokers than ex-smokers and non-smokers (adjusted p value: current vs non-smoker = 0.04; current vs ex-smoker = 0.05). Current smokers had axPsA more often than ex-smokers and non-smokers (Supplementary Table 2).

Disease characteristics in patients with and without axPsA

According to the rheumatologist, 454 (29.6%) had axial involvement. Only 7.1% (109/1535) of patients with PsA had axial disease only, without peripheral arthritis. Patients with axPsA were more frequently males and younger compared to patients without axPsA (non-axPsA). There were more current smokers in axPsA patients than non-axPsA participants, compared to ex-smokers and non-smokers. Smoking pack-years were found similar between groups. Patients with axPsA also had more frequent nail disease (Table 1, and Supplementary Table 1, available from the authors on request).

Multivariable analyses for prediction of axial disease

Multivariable analysis to predict axPsA showed that younger age, male sex, current smoking, and nail disease were significant predictors for axPsA, whereas the presence of polyarticular peripheral arthritis and distal interphalangeal joint involvement were protective (Table 2). Ex-smoking did not have any effect on axPsA, similar to non-smokers.

View this table:
  • View inline
  • View popup
Table 2.

Univariable and multivariable analysis on factors associated with axial psoriatic arthritis.

The multivariable analysis was also repeated by excluding patients who did not fulfill the Classification Criteria for Psoriatic Arthritis (CASPAR), which revealed similar results (data not shown).

The effect of smoking on radiographic sacroiliitis

Of the patients with axPsA, 187 (41.2%) had available SIJ radiographs for central reading and 137 (73.2%) of them had radiographic sacroiliitis according to the mNY criteria. Current smoking was more frequent in patients with sacroiliitis (sacroiliitis vs no sacroiliitis: current smoking = 39% vs 20%; ex-smoking = 15.3% vs 20%; non-smoking = 45.3% vs 60%; p = 0.05). Smoking pack-years were higher in patients with sacroiliitis [16.7 (13.5) vs 10.9 (11.5), p = 0.030]. Patients with sacroiliitis had significantly higher Health Assessment Questionnaire (HAQ) score and lower BMI, whereas age, sex, disease characteristics, and activity scores were similar (Supplementary Table 3, available from the authors on request).

In the multivariable model, current smoking status and higher HAQ scores had increased risk for radiographic sacroiliitis (Table 3).

View this table:
  • View inline
  • View popup
Table 3.

Univariable and multivariable analysis of factors associated with radiographic sacroiliitis.

DISCUSSION

Smoking has been shown to be a risk factor in many immune-mediated diseases12. There is a clear link between smoking and new bone formation, as demonstrated in AS and axSpA; however, the underlying mechanism has not been clearly understood13,14. Previous studies suggest that smoking has effects on both cellular and humoral components of the immune system, which include leukocytosis, decreased leukocyte function, and increasing some of the cytokines and soluble receptors [interleukin (IL) 15, IL-1Ra, IL-6, sIL-6R, and vascular endothelial growth factor receptor 3], as well as generation of reactive oxygen species. Smoking may be triggering the tissue hypoxia and increasing danger signals, similar to the effect of mechanical stress15,16. We hypothesize that a similar relationship between smoking and structural damage may also be underlying in patients with PsA. Herein we demonstrated that smoking is more linked to a specific phenotype in PsA: axial disease. In addition, current smoking also increased the risk of sacroiliitis with an OR of 6.6. These observations are parallel to what has been observed in AS. The differences across PsA studies can be due to the heterogeneity of the PsA population and representation of different subtypes with different frequencies.

AxPsA does not have a definition that is universally agreed upon. Some studies have used only the clinician’s diagnosis17, whereas others have mandated the presence of sacroiliitis18. The definition of imaging findings was initially developed in AS. Because differences in imaging findings have been demonstrated in AS and axPsA, whether the same set of imaging criteria can be used in axPsA requires further testing. In addition, the inflammatory back pain (IBP) criteria were also developed for AS and we have previously shown that those criteria lack sensitivities in axPsA, mostly due to age at onset of symptoms. In another study, in axSpA patients with clear imaging findings, a subset of patients with psoriasis had the onset of back pain after the age of 45, raising a concern about the validity of the IBP criteria in axPsA. In the absence of a widely accepted definition, we have chosen the rheumatologists’ decisions for axPsA because that would have implications on their management of the disease. The Assessment of Spondyloarthritis international Society and Group for Research and Assessment of Psoriasis and Psoriatic Arthritis are currently working on the definition of axPsA criteria; it is hoped that will standardize future studies and registries.

AxPsA was reported in around 30% in our registry, comparable to the previous reports19. In addition to the effect of smoking, our study found similar results with the previously demonstrated risk factors for axPsA, such as younger age, male sex, and nail disease, supporting its external validation17,19.

Our study has some limitations. Genetic data or biomarkers were not systematically collected; therefore, the effect of HLA-B27 could not be analyzed. The number of complete sets of spinal radiographs was low and could not be further evaluated. Also due to the cross-sectional design, our results cannot support conclusions on causal relationships.

Both axPsA and radiographic sacroiliitis are more frequent among current smokers, but not ex-smokers, similar to the observations in AS. The differences between current and ex-smoking are intriguing. If smoking cessation is proven to reduce to risk of axPsA in prospective studies, it can be prioritized for the prevention of axPsA among patients with psoriasis.

Acknowledgment

We thank all the collaborators for their participation.

APPENDIX 1. List of study collaborators.

Orhan Kucuksahin, MD, Ankara Yildirim Beyazit University, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey

Emine Figen Tarhan, Associate Professor, Mugla Sitki Kocman University, Department of Internal Medicine, Division of Rheumatology, Mugla, Turkey

Servet Akar, MD, Professor, Izmir Katip Celebi University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey

Emine Duygu Ersozlu, MD, Associate Professor, Adana Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Adana, Turkey

Muge Aydin Tufan, Associate Professor, Gazi University, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey

Seval Pehlivan, MD, Fatih University, Department of Physical Therapy and Rehabilitation, Istanbul, Turkey

Muhammed Cinar, MD, Associate Professor, Gulhane School of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey

Fatih Yildiz, MD, Van Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Van, Turkey

Emel Gonullu, MD, Eskisehir Osmangazi University, Department of Internal Medicine, Division of Rheumatology, Eskisehir, Turkey

Serpil Ergulu Esmen, MD, Konya Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey

Adem Kucuk, MD, Malatya State Hospital, Department of Internal Medicine, Division of Rheumatology, Malatya, Turkey

Ayse Balkarli, MD, Antalya Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Antalya, Turkey

Tuncay Duruoz, MD, Professor, Marmara University, Department of Physical Medicine and Rehabilitation, Istanbul, Turkey

Ridvan Mercan, MD, Namik Kemal University, Department of Internal Medicine, Division of Rheumatology, Tekirdag, Turkey

Abdurrahman Tufan, Associate Professor, Gazi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey

Timucin Kasifoglu, MD, Eskisehir Osmangazi University, Department of Internal Medicine, Division of Rheumatology, Eskisehir, Turkey

Veli Yazisiz, MD, Associate Professor, Akdeniz University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Antalya, Turkey

Funda Erbasan, Antalya Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Antalya, Turkey

Senol Kobak, MD, Associate Professor, Istinye University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

Soner Senel, MD, Associate Professor, Erciyes University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Kayseri, Turkey

Baris Yilmazer, MD, Trakya University, Department of Internal Medicine, Division of Rheumatology, Edirne, Turkey

Lutfu Akyol, MD, Ondokuz Mayis University, Department of Internal Medicine, Division of Rheumatology, Samsun, Turkey

Sukran Ertan, MD, Ankara Yildirim Beyazit University, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey

Hamide Kart Koseoglu, TOBB ETU University, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey

Cemal Bes, MD, Associate Professor, Bakirkoy Sadi Konuk Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

Sule Yavuz, MD, Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology Istanbul, Turkey

Ali Sahin, MD, Cumhuriyet University, Department of Internal Medicine, Division of Rheumatology, Sivas, Turkey

Ismail Dogan, MD, Hitit University, Department of Internal Medicine, Division of Rheumatology, Corum, Turkey

Omer Karadag, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey

Footnotes

  • D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi.

  • Accepted for publication November 13, 2019.

REFERENCES

  1. 1.↵
    1. Gladman DD
    . Clinical features and diagnostic considerations in psoriatic arthritis. Rheum Dis Clin North Am 2015;41:569–79.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Li W,
    2. Han J,
    3. Qureshi AA
    . Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 2012;71:804–8.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Nguyen UD,
    2. Zhang Y,
    3. Lu N,
    4. Louie-Gao Q,
    5. Niu J,
    6. Ogdie A,
    7. et al.
    Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis 2018;77:119–23.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Eder L,
    2. Shanmugarajah S,
    3. Thavaneswaran A,
    4. Chandran V,
    5. Rosen CF,
    6. Cook RJ,
    7. et al.
    The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis 2012;71:219–24.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Tey HL,
    2. Ee HL,
    3. Tan AS,
    4. Theng TS,
    5. Wong SN,
    6. Khoo SW
    . Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol 2010;37:426–30.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Pattison E,
    2. Harrison BJ,
    3. Griffiths CE,
    4. Silman AJ,
    5. Bruce IN
    . Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 2008;67:672–6.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Poddubnyy D,
    2. Haibel H,
    3. Listing J,
    4. Märker-Hermann E,
    5. Zeidler H,
    6. Braun J,
    7. et al.
    Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC). Ann Rheum Dis 2013;72:1430–2.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Videm V,
    2. Cortes A,
    3. Thomas R,
    4. Brown MA
    . Current smoking is associated with incident ankylosing spondylitis - the HUNT population-based Norwegian health study. J Rheumatol 2014;41:2041–8.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Kalyoncu U,
    2. Bayindir O,
    3. FerhatOksuz M,
    4. Doğru A,
    5. Kimyon G,
    6. Tarhan EF,
    7. et al;
    8. Psoriatic Arthritis Registry of Turkey Study Group
    . The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatology 2017;56:279–86.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. van der Linden S,
    2. Valkenburg H,
    3. Cats A
    . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Aydin SZ,
    2. Kucuksahin O,
    3. Kilic L,
    4. Dogru A,
    5. Bayindir O,
    6. Ozisler C,
    7. et al.
    Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life. Clin Rheumatol 2018;37:3443–8.
    OpenUrl
  12. 12.↵
    1. Rahman P,
    2. Inman RD,
    3. El-Gabalawy H,
    4. Krause DO
    . Pathophysiology and pathogenesis of immune-mediated inflammatory diseases: commonalities and differences. J Rheumatol 2010;Suppl 85:11–26.
  13. 13.↵
    1. Poddubnyy D,
    2. Haibel H,
    3. Listing J,
    4. Märker-Hermann E,
    5. Zeidler H,
    6. Braun J,
    7. et al.
    Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012;64:1388–98.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Ward MM,
    2. Hendrey MR,
    3. Malley JD,
    4. Learch TJ,
    5. Davis JC,
    6. Reveille JD,
    7. et al.
    Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Care Res 2009;61:859–66.
    OpenUrlCrossRef
  15. 15.↵
    1. Sopori M
    . Effects of cigarette smoke on the immune system. Nature Rev Immunol 2002;2:372–7.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Pachero-Tena C,
    2. Gonzalez-Chavez SA
    . The danger model approach to the pathogenesis of the rheumatic diseases. J Immonol Res 2015;2015:506089.
    OpenUrl
  17. 17.↵
    1. Mease PJ,
    2. Palmer JB,
    3. Liu M,
    4. Kavanaugh A,
    5. Pandurengan R,
    6. Ritchlin CT,
    7. et al.
    Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. J Rheumatol 2018;45:1389–96.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Jadon DR,
    2. Senguota R,
    3. Nigthingale A,
    4. Lindsay M,
    5. Korendowych E,
    6. Robinson G,
    7. et al.
    Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis 2017;76:701–7.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Chandran V,
    2. Tolusso DC,
    3. Cook RJ,
    4. Gladman DD
    . Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. J Rheumatol 2010;37:809–15.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 47, Issue 9
1 Sep 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Current Smoking Is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Current Smoking Is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis
Dilek Solmaz, Umut Kalyoncu, Ilaria Tinazzi, Sibel Bakirci, Ozun Bayindir, Atalay Dogru, Ediz Dalkilic, Gezmis Kimyon, Cem Ozisler, Gozde Yildirim Cetin, Levent Kilic, Ahmet Omma, Meryem Can, Sema Yilmaz, Abdulsamet Erden, Sibel Zehra Aydin
The Journal of Rheumatology Sep 2020, 47 (9) 1354-1358; DOI: 10.3899/jrheum.190722

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Current Smoking Is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis
Dilek Solmaz, Umut Kalyoncu, Ilaria Tinazzi, Sibel Bakirci, Ozun Bayindir, Atalay Dogru, Ediz Dalkilic, Gezmis Kimyon, Cem Ozisler, Gozde Yildirim Cetin, Levent Kilic, Ahmet Omma, Meryem Can, Sema Yilmaz, Abdulsamet Erden, Sibel Zehra Aydin
The Journal of Rheumatology Sep 2020, 47 (9) 1354-1358; DOI: 10.3899/jrheum.190722
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • APPENDIX 1. List of study collaborators.
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

AXIAL PSORIATIC ARTHRITIS
SMOKING
SACROILIITIS

Related Articles

Cited By...

More in this TOC Section

  • Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
  • Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis
  • Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs
Show more Psoriatic Arthritis

Similar Articles

Keywords

  • AXIAL PSORIATIC ARTHRITIS
  • smoking
  • sacroiliitis

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire